Drugs / Doxorrubicine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00849355 | Aug 2008 → Nov 2009 | B-cell non-Hodgkin lymphoma | Asociacion Doctor Peset Para el Estudio de la Hematología | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Doxorrubicine | “Treatment: rituximab 375m/m2 + ciclophosphamide 750 mg/m2 + Vincristine 1.4 mg/m2 + Doxorrubicine 50 mg/m2 at day 1 and every 14d.” NCT00849355 ↗ |
| Known as | Myocet | “lyposomal Doxorrubicine (Myocet)” NCT00849355 ↗ |